Geneva, June 22 -- International Clinical Trials Registry received information related to the study (NCT07645807) titled 'An Investigator-Initiated, Randomized, Double-Blind, Double-Dummy Study to Evaluate the Adjunctive Effect of CreNeuroS™ CNS Fish Oil Plus Softgels in Patients With Major Depressive Disorder Receiving Escitalopram' on June 9.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Supportive Care. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Sichuan Credit Pharmaceutical Co., Ltd.
Condition:
Adjunct in the Treatment of Depressive Disorder
Intervention:
Combination Product: Escitalopram (...